Back to search
FDAFDA · Food and drugs·Recall number D-0312-2021

Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo, CA 93012-8601 USA, NDC 51407-129-10

Published March 31, 2021 · Recall initiated: March 19, 2021

Summary

FDA records drug Class II recall D-0312-2021, published March 31, 2021 and initiated March 19, 2021. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot #: GS029673, Exp. Date 5/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Golden State Medical Supply Inc.
Distributor
Sold to two wholesalers/distributors under government contract located in PA and TX
Lot
Lot #: GS029673, Exp. Date 5/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo, CA 93012-8601 USA, NDC 51407-129-10 recalled?

Yes. FDA published recall D-0312-2021 on March 31, 2021. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer

What should I do if I have this product?

Voluntary: Firm initiated · Letter